logo-loader
OptiBiotix Health PLC

OptiBiotix Health inks deal in Japan to develop cardiovascular health supplements

The plan is also to obtain an authorised cardiovascular health claim for the OptiBiotix technology

picture of a heart
The idea is to incorporate LPLDL into heart-healthy food supplements for the Japanese market

OptiBiotix Health PLC (LON:OPTI) continues to gain commercial traction for its healthcare products focused on the human microbiome.

Its latest deal is with the Japanese group Tenshindo, a manufacturer of functional foods and cosmetics, which has signed a licence agreement for the UK group’s Lactobacillus plantarum (LPLDL) bacteria strain.

The idea is to incorporate LPLDL into heart-healthy food supplements, while the pair are aiming to obtain an authorised cardiovascular claim for the OptiBiotix technology.

Gaining validation of this kind, which would be based on existing clinical and market evidence, would be “highly advantageous from the commercial point of view, but also an important endorsement for [the] science”, said Dr Luis Gosalbez, business development director of OptiBiotix.

Latest of series of deals 

The tie-up for the AIM-listed firm’s ProBiotix Health division is the latest in a series of commercial agreements.

Earlier this week it teamed with Kappa Biosciences of Norway to create a new vascular health product in Europe.

Meanwhile, last month it named a partner to bring its weight management technology to North America.

OptiBiotix’s compounds have been created to tackle obesity, cardiovascular disease and diabetes.

And, as mentioned above, they are focused on the human microbiome, an ecosystem of bacteria found in the gut or on the skin.

Quick facts: OptiBiotix Health PLC

Price: 52.58 GBX

Market: AIM
Market Cap: £44.92 m
Follow

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of OptiBiotix Health PLC named herein, including the promotion by the Company of OptiBiotix Health PLC in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

2 min read